U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399665) titled 'ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia' on Nov. 24, 2025.
Brief Summary: ARES is a multi-centre, retrospective-prospective, non-comparative and non-interventional (observational) cohort study involving primary and secondary data collection within real-world settings of participants who have initiated tezepelumab (no more than 4 weeks before inclusion) for treatment of CRSwNP (with or without comorbid asthma).
Study Start Date: Dec. 25, 2025
Study Type: OBSERVATIONAL
Condition:
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Asthma
Recruitment Status: RECRUITING
Sponsor: As...